Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid Tumors
Clinical trial NCT03348514 · COMPLETED
Trial details
- NCT number
- NCT03348514
- Sponsor
- CicloMed LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-15
- Primary completion
- 2020-05-31
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.